Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2019 Filed Jun 20, 2019 20:51 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 770 | $48.71 | $37,506.70 |
DisclosureSEC source: 0001099219-19-000116 · wf-form4_156106386201627.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,782 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:06 UTC |
Lee EstherEVP & Chief Marketing Officer
|
GrantCommon Stock | 113 | $48.51 | $5,481.63 |
DisclosureSEC source: 0001099219-19-000082 · wf-form4_156081275003561.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP & Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,715 F1 · kind: Represents imputed reinvested dividends in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:07 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 20 | $48.51 | $970.20 |
DisclosureSEC source: 0001099219-19-000084 · wf-form4_156081286374057.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,207 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:04 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 279 | $48.51 | $13,534.29 |
DisclosureSEC source: 0001099219-19-000080 · wf-form4_156081265391341.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,909 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:02 UTC |
KILTS JAMES MDirector
|
GrantDeferred Share Equivalents · Derivative | 105 | $48.51 | $5,093.55 |
DisclosureSEC source: 0001099219-19-000078 · wf-form4_156081256213303.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,707 Underlying: Common Stock · 105 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F4 · timeliness: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F3 · price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · balance_after: Deferred Share Equivalents were previously referred to as "Common Stock Equivalent Units." Beginning with this report, the Reporting Person will report the total of all the person's Deferred Share Equivalents in Table II Box 9. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:02 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 480 | $48.51 | $23,284.80 |
DisclosureSEC source: 0001099219-19-000078 · wf-form4_156081256213303.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,379 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:01 UTC |
Kennard William EDirector
|
GrantCommon Stock | 178 | $48.51 | $8,634.78 |
DisclosureSEC source: 0001099219-19-000076 · wf-form4_156081245975434.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,797 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:59 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 134 | $48.51 | $6,500.34 |
DisclosureSEC source: 0001099219-19-000074 · wf-form4_156081236450151.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,953 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:57 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantDeferred Share Equivalents · Derivative | 205 | $48.51 | $9,944.55 |
DisclosureSEC source: 0001099219-19-000072 · wf-form4_156081224983346.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,763 Underlying: Common Stock · 205 shares Expires not disclosed F2 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F2 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · balance_after: Deferred Share Equivalents were previously referred to as "Common Stock Equivalent Units." Beginning with this report, the Reporting Person will report the total of all the person's Deferred Share Equivalents in Table II Box 9. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:57 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 423 | $48.51 | $20,519.73 |
DisclosureSEC source: 0001099219-19-000072 · wf-form4_156081224983346.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,783 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:55 UTC |
Herzog David LDirector
|
GrantCommon Stock | 31 | $48.51 | $1,503.81 |
DisclosureSEC source: 0001099219-19-000070 · wf-form4_156081211961898.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,514 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:53 UTC |
HASSELL GERALD LDirector
|
GrantDeferred Share Equivalents · Derivative | 16 | $48.51 | $776.16 |
DisclosureSEC source: 0001099219-19-000068 · wf-form4_156081197720756.xml · derivative · entry 2 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,795 Underlying: Common Stock · 16 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · balance_after: Deferred Share Equivalents were previously referred to as "Common Stock Equivalent Units." Beginning with this report, the Reporting Person will report the total of all the person's Deferred Share Equivalents in Table II Box 9. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:53 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 40 | $48.51 | $1,940.40 |
DisclosureSEC source: 0001099219-19-000068 · wf-form4_156081197720756.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,517 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. F2 · balance_after: Includes 29 shares previously reported as indirectly owned in the MetLife Policyholder Trust. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:51 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 479 | $48.51 | $23,236.29 |
DisclosureSEC source: 0001099219-19-000066 · wf-form4_156081185055573.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,012 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| May 01, 2019 Filed May 1, 2019 22:37 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantDeferred Share Equivalents · Derivative | 283 | $45.71 | $12,935.93 |
DisclosureSEC source: 0001209191-19-026865 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,559 Underlying: Common Stock · 283 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person previously chose to defer his cash fees under the MetLife Deferred Compensation Plan for Non-Management Directors. The Reporting Person chose simulated investment in MetLife, Inc. common stock for a portion of those deferred cash fees. As a result, the Reporting Person acquired the Deferred Share Equivalents reported here. Each Deferred Share Equivalent (formerly referred to as Common Stock Equivalent Units) is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · kind: The Reporting Person, a non-management director of MetLife, Inc., became Chairman of the Board of Directors on May 1, 2019. He previously served as Lead Director. Under MetLife, Inc.'s non-management director compensation arrangements, the Reporting Person's Board Chair cash fees for May 1 through June 17, 2019 became due on May 1. The Company reduced the amount due by the amount it previously paid the Reporting Person as Lead Director cash retainer fees for the same period. F1 · derivative.exercise_date: The Reporting Person previously chose to defer his cash fees under the MetLife Deferred Compensation Plan for Non-Management Directors. The Reporting Person chose simulated investment in MetLife, Inc. common stock for a portion of those deferred cash fees. As a result, the Reporting Person acquired the Deferred Share Equivalents reported here. Each Deferred Share Equivalent (formerly referred to as Common Stock Equivalent Units) is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F1 · derivative.expiration_date: The Reporting Person previously chose to defer his cash fees under the MetLife Deferred Compensation Plan for Non-Management Directors. The Reporting Person chose simulated investment in MetLife, Inc. common stock for a portion of those deferred cash fees. As a result, the Reporting Person acquired the Deferred Share Equivalents reported here. Each Deferred Share Equivalent (formerly referred to as Common Stock Equivalent Units) is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:38 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock Equivalent Units · Derivative | 340 | $44.13 | $15,004.20 |
DisclosureSEC source: 0001209191-19-022546 · doc4.xml · derivative · entry 3 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340 Underlying: Common Stock · 340 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:38 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022546 · doc4.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,447 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:41 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022559 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,819 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:44 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022584 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,384 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:43 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022578 · doc4.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,187 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:43 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022573 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,630 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:42 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022567 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,899 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:41 UTC |
Kennard William EDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022565 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,619 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:40 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 567 | $44.13 | $25,021.71 |
DisclosureSEC source: 0001209191-19-022555 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567 Underlying: Common Stock · 567 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:40 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022555 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,361 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:39 UTC |
Herzog David LDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022551 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,483 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:38 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022540 · doc4.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,418 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:37 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022533 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,533 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:41 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 130 | $44.70 | $5,811.00 |
DisclosureSEC source: 0001209191-19-019476 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,969 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:46 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 279 | $44.70 | $12,471.30 |
DisclosureSEC source: 0001209191-19-019486 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,780 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:47 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 12 | $44.70 | $536.40 |
DisclosureSEC source: 0001209191-19-019487 · doc4.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,337 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:44 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock Equivalent Units · Derivative | 108 | $44.70 | $4,827.60 |
DisclosureSEC source: 0001209191-19-019484 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108 Underlying: Common Stock · 108 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · timeliness: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:44 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 485 | $44.70 | $21,679.50 |
DisclosureSEC source: 0001209191-19-019484 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,049 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:43 UTC |
Kennard William EDirector
|
GrantCommon Stock | 175 | $44.70 | $7,822.50 |
DisclosureSEC source: 0001209191-19-019480 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,769 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:40 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantCommon Stock | 1,550 | $44.70 | $69,285.00 |
DisclosureSEC source: 0001209191-19-019474 · doc4.xml · nonDerivative · entry 1 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620,157 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:39 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 202 | $44.70 | $9,029.40 |
DisclosureSEC source: 0001209191-19-019470 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202 Underlying: Common Stock · 202 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:39 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 426 | $44.70 | $19,042.20 |
DisclosureSEC source: 0001209191-19-019470 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,511 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:38 UTC |
Herzog David LDirector
|
GrantCommon Stock | 24 | $44.70 | $1,072.80 |
DisclosureSEC source: 0001209191-19-019468 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,633 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:36 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 484 | $44.70 | $21,634.80 |
DisclosureSEC source: 0001209191-19-019464 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,683 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:37 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock Equivalents Units · Derivative | 13 | $44.70 | $581.10 |
DisclosureSEC source: 0001209191-19-019467 · doc4.xml · derivative · entry 3 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13 Underlying: Common Stock · 13 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:37 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 33 | $44.70 | $1,475.10 |
DisclosureSEC source: 0001209191-19-019467 · doc4.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,597 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:19 UTC |
TADROS RAMYEVP & Chief Risk Officer
|
GrantRestricted Stock Units · Derivative | 659 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017162 · doc4.xml · derivative · entry 3 TADROS RAMY · CIK 0001714199 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320 Underlying: Common Stock · 659 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F3 · derivative.expiration_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:19 UTC |
TADROS RAMYEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 263 | $45.66 | $12,008.58 |
DisclosureSEC source: 0001209191-19-017162 · doc4.xml · nonDerivative · entry 2 TADROS RAMY · CIK 0001714199 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Stock Unit payout. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:19 UTC |
TADROS RAMYEVP & Chief Risk Officer
|
Exercise / conversionCommon Stock | 659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017162 · doc4.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:19 UTC |
SCHMIDT OSCARPresident, Latin America
|
Exercise / conversionRestricted Units (Cash Payable) · Derivative | 3,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017160 · doc4.xml · derivative · entry 9 SCHMIDT OSCAR · CIK 0001738204 · President, Latin America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,594 Underlying: Common Stock · 3,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Unit is the contingent right to receive cash equal to the closing price of one share of MetLife, Inc. common stock on the vesting date. F3 · derivative.exercise_date: The Restricted Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F3 · derivative.expiration_date: The Restricted Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:19 UTC |
SCHMIDT OSCARPresident, Latin America
|
Disposition to issuerCommon Stock | 3,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017160 · doc4.xml · nonDerivative · entry 6 SCHMIDT OSCAR · CIK 0001738204 · President, Latin America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:19 UTC |
SCHMIDT OSCARPresident, Latin America
|
Exercise / conversionCommon Stock | 3,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017160 · doc4.xml · nonDerivative · entry 5 SCHMIDT OSCAR · CIK 0001738204 · President, Latin America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Unit is the contingent right to receive cash equal to the closing price of one share of MetLife, Inc. common stock on the vesting date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:18 UTC |
Ponnavolu KishorePresident, Asia
|
Exercise / conversionRestricted Stock Units · Derivative | 1,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017158 · doc4.xml · derivative · entry 9 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,015 Underlying: Common Stock · 1,007 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. F4 · derivative.expiration_date: The Restricted Stock Units vest in three installments on the first business day in March on or following each of the first three anniversaries of the Grant Date. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:18 UTC |
Ponnavolu KishorePresident, Asia
|
Tax withholdingCommon Stock | 316 | $45.66 | $14,428.56 |
DisclosureSEC source: 0001209191-19-017158 · doc4.xml · nonDerivative · entry 6 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,668 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Stock Unit payout. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 01:18 UTC |
Ponnavolu KishorePresident, Asia
|
Exercise / conversionCommon Stock | 1,007 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-017158 · doc4.xml · nonDerivative · entry 5 Ponnavolu Kishore · CIK 0001751468 · President, Asia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.